When I looked through an epidemiological report in The New England Journal of Medicine (a study by Jeffrey Kwong and colleagues covering 19,729 patients over age 35), one contrast jumped right off the page. During the first 7 days after a lab-confirmed flu infection, the risk of being hospitalized with an acute myocardial infarction—the death of part of the heart muscle from a blocked artery—jumps 6.05-fold, and with influenza B it spikes 10.11-fold. Yet once you clear that first week of illness, the surge drops off and your risk returns to baseline.
Most people treat seasonal shots as basic insurance against a runny nose and a week under a thermometer. So when a cardiologist tells someone with high blood pressure or atherosclerosis to get vaccinated against the flu and pneumococcus, the first reaction is predictable: "Doctor, what does my heart have to do with it if I barely ever catch colds?" As cardiologist Anton Utin explains (Doctor Utin), both the European Society of Cardiology and the American College of Cardiology put vaccination alongside statins and blood-pressure medication not for your airways' sake—the shot shields your coronary arteries from an inflammatory catastrophe.
Why a Respiratory Virus Hits Coronary Arteries, Not Just Your Airways
Take an everyday scenario. A 58-year-old man works full-time, takes medication for high blood pressure, and has a small, quiet plaque in his carotid artery that showed up years ago on a neck ultrasound. Every fall, he brushed off the flu shot: "I hardly ever get sick, and if I do, I'll just stay home, drink hot tea for a couple of days, and bounce right back." That worked fine until one November, when he caught a severe case of the flu with a 39 °C fever and a resting heart rate pounding out of his chest.
When a respiratory virus enters your airways, your body cranks up a fever, and your cardiovascular system takes the first hit. Every 1 °C rise in body temperature speeds up your pulse by 8–10 beats per minute, while your upper (systolic) blood pressure climbs. With a high fever, our guy's heart is running in overdrive around the clock, squeezing in twenty extra beats every minute even while he is lying on his pillow.
Picture a car engine hauling a trailer up a steep hill at high RPMs: it burns through far more fuel and air. In the same way, a heart muscle strained by tachycardia desperately needs extra oxygen. At the same time, viral intoxication and swollen airways lower blood oxygen levels. Inside the coronary arteries, a dangerous gap opens between what the heart muscle demands and what the blood can deliver, triggering oxygen starvation.
How a Plaque Ruptures: Fever, Inflammation, and Clotting
You might be thinking: sure, fever speeds up the pulse, but why would someone with a stable plaque—sitting quietly in an artery wall for years—suddenly have a heart attack? I wondered the exact same thing when reading up on the pathophysiology of acute coronary syndromes, and the answer comes down to two triggers of systemic inflammation.
You can think of an atherosclerotic plaque as a soft, fatty pocket tucked into the inner wall of a pipe and sealed from above by a tough connective-tissue film—a fibrous cap made of collagen. As long as the body is calm, that dome holds firm. But once a virus starts replicating, it trips a fire alarm across the entire body: a systemic inflammatory storm. Your immune system floods the bloodstream with signaling proteins called cytokines. They wake up immune cells (macrophages) inside the plaque's lining, which release enzymes that chew away at the collagen framework of the cap. The film thins out like tissue paper. We saw a similar process play out over years when looking at how chronic gum inflammation damages carotid artery walls—except with the flu, that blow is compressed into just a few days.
The second trigger fires when rapid heartbeats and blood-pressure spikes crack that thinned-out cap, exposing the fatty core directly to the bloodstream. Systemic inflammation has already shifted your blood into high-clotting mode: fibrinogen levels climb while natural anticoagulants are dialed down. Platelets clump instantly at the tear, and within minutes a clot forms and blocks the coronary artery.
The Evidence: The IAMI Trial, a 40% Drop in Mortality, and Meta-Analyses
Our patient with hypertension got off with a scare that November week—an ambulance call at the peak of his tachycardia and an unscheduled trip to his cardiologist. Still, his close call highlights a fundamental rule: if you defuse the viral detonator ahead of time, the vascular chain reaction never starts.
I checked the protocol of the international double-blind, placebo-controlled IAMI trial published in Circulation. Physicians across 30 cardiology centers in 8 countries followed 2,571 patients (2,532 included in the primary analysis) right after a heart attack or stent placement. Still in the hospital, within the first 72 hours of their vascular procedure, half the participants received an inactivated flu vaccine and the other half received saline (placebo).
Twelve months later, cardiovascular mortality among vaccinated patients was 40% lower: 27 deaths per 1,000 vaccinated patients (2.7%) compared with 45 in the placebo group (4.5%). All-cause mortality fell from 4.9% to 2.9%, and the combined risk of death, another heart attack, or stent thrombosis dropped by 28% (5.3% vs. 7.2%).
A meta-analysis of six randomized trials in patients after acute coronary events backs this up: serious complications occurred in 6.5% of vaccinated patients versus 11% in controls. And in older adults, high-dose flu vaccines protected against heart-related hospitalizations even better than standard doses.
Your Vascular Protection Calendar: Annual Flu, Scheduled Pneumococcal Shots, and RSV Limits
After living through that scare, our patient put vaccines right onto his personal calendar alongside his blood-pressure pills. Home remedies simply cannot stop a viral storm—as we already covered when explaining why mega-doses of vitamin C, ginger, and honey won't protect you from seasonal infections.
First in line for protection are people with coronary artery disease, a past heart attack, stage II–III hypertension, heart failure, type 2 diabetes, and everyone over 60. If you are unsure where your blood vessels stand, check out our guide to free heart and vascular screenings under public health insurance (OMS).
- Flu—every fall. The sweet spot is September through November, before the seasonal wave hits. Trivalent and quadrivalent inactivated vaccines contain no live virus and train your immune system to shut down the infection without an inflammatory explosion.
- Pneumococcus—by schedule. Streptococcus pneumoniae threatens more than just pneumonia, the risk of which drops by nearly half in adults 65 and older after vaccination. According to meta-analyses, the 23-valent vaccine lowers cardiovascular event risk in older adults by 10%. It is given as a single dose or as a sequence of the conjugate vaccine
PCV13and polysaccharide vaccinePPSV23spaced according to your doctor's plan. - Respiratory syncytial virus (RSV). Among adults over 50 hospitalized with RSV, an acute cardiac complication—most often acute heart failure—strikes one in five (20%), and one in three (33%) among those with existing heart disease. The
ArexvyandAbrysvovaccines are approved in the US and Europe, but as of 2026, adult RSV vaccines are not registered in Russia, making flu and pneumococcal shots our core shield.
Vaccination does not dissolve existing plaques or replace statins and blood-pressure medication—it only removes an acute trigger for plaque rupture. Shots are postponed during an acute fever until temperature returns to normal, and standard egg-based vaccines are contraindicated in people with an anaphylactic allergy to egg protein.
Keep three practical rules in mind:
- Match your vaccines to your vascular profile. If you are older or live with hypertension, atherosclerosis, coronary artery disease, or diabetes, treat fall respiratory bugs as a direct cardiac risk.
- Plan your flu shot for September–November. Your immune system needs about two weeks to build antibodies before winter infections peak.
- Ask your doctor about pairing flu and pneumococcal protection. At your next primary-care or cardiology visit, confirm which pneumococcal schedule fits your case.
Looking after your heart muscle does not always mean complicated interventions. Sometimes the smartest investment in a quiet winter for your heart takes fifteen minutes in a clinic chair.

